(Q67940781)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

In vitro synergistic activity of PDN-IFN alpha and NM + IFN alpha combinations on fresh bone-marrow samples from multiple myeloma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

E Lepri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

A Barzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

E Menconi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

M G Portuesi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

M Liberati

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

publication date

1 March 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

published in

Hematological Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

79-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090203

7 January 2021

Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090203

7 January 2021

Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090203

7 January 2021

Interferon exerts a cytotoxic effect on primary human myeloma cells

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090203

7 January 2021

Multiple myeloma in central Norway 1981-1982: a randomized clinical trial of 5-drug combination therapy versus standard therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090203

7 January 2021

Long-term survival in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090203

7 January 2021

Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090203

7 January 2021

Identifiers

DOI

10.1002/HON.2900090203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1869244%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference